The Society of Cannabis Clinicians is pleased to announce our partnership with CannaKeys, providing SCC members with an exclusive discounted subscription. This collaboration ensures access to the latest research and treatment algorithms, empowering clinicians with evidence-based insights at their fingertips.
At CannaKeys, we strive to demystify the emerging field of the cannabinoid health sciences and reinforce the proper pathways for patient care utilizing cannabis and related therapies. We do this by creating platforms that offer easy access to the published science, aggregated critical data points, and guidance to practitioners and patients to ask the right questions and achieve optimal results more quickly.
Our mission is to empower patients, medical professionals, and caregivers with the tools to maximize the effectiveness of cannabis therapeutics and create agency with regard to their applications.
The future of cannabis therapeutics will be based on chemotype-based prescribing informed by quality science and patient trends.
**SCC members receive 25% off of the CannaKeys subscription plan; please log into your member account to view the discount code.**
